SynthesisBMC cancer2025

Efficacy and safety of PD-1/PD-L1 inhibitors for natural killer/T-cell lymphoma: a single-arm meta-analysis.

Jiao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.